Mohammad E. Khamseh

Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals

Mansour Sedighi, Shabnam Razavi, Fatemeh Navab-Moghadam et al. · Microbial Pathogenesis · 2017 · 303 citations

Life Sciences, Immunology, Microbiology +16

Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study

León Litwak, Su‐Yen Goh, Zanariah Hussein et al. · Diabetology & Metabolic Syndrome · 2013 · 284 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Hoda Taheri, Mojtaba Malek, Faramarz Ismail‐Beigi et al. · Advances in Therapy · 2020 · 186 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity

Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi et al. · Metabolic Syndrome and Related Disorders · 2020 · 169 citations

Medicine, Internal Medicine, Pathology +17

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Haleh Chehrehgosha, Masoudreza Sohrabi, Faramarz Ismail‐Beigi et al. · Diabetes Therapy · 2021 · 169 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17